FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38383211000001107: Erlotinib 25mg tablets (Accord Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-May 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1331491000001119 Erlotinib 25mg tablets (Accord Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1331501000001111 Erlotinib 25mg tablets (Accord Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erlotinib 25mg tablets (Accord Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Erlotinib 25mg tablets (Accord Healthcare Ltd) Is a Product containing precisely erlotinib (as erlotinib hydrochloride) 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Erlotinib 25mg tablets (Accord Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Erlotinib 25mg tablets (Accord Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Erlotinib 25mg tablets (Accord Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Erlotinib 25mg tablets (Accord Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Erlotinib 25mg tablets (Accord Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erlotinib 25mg tablets (Accord Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erlotinib true Inferred relationship Existential restriction modifier
Erlotinib 25mg tablets (Accord Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erlotinib 25mg tablets (Accord Healthcare Ltd) Has specific active ingredient Erlotinib hydrochloride true Inferred relationship Existential restriction modifier
Erlotinib 25mg tablets (Accord Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Erlotinib 25mg tablets (Accord Healthcare Ltd) 30 tablet 3 x 10 tablets Has AMP True Erlotinib 25mg tablets (Accord Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start